Teradyne Inc (TER)
Official siteTECHNOLOGY • SEMICONDUCTOR EQUIPMENT & MATERIALS • NASDAQ
Market Cap: $38.96B
Last updated: Nov 17, 2026 at 11:06 AM ET
Teradyne Inc (TER) Financials: Revenue, Profit and Cash Flow
Teradyne reported revenue of $3.19B for the fiscal year ended Dec 31, 2025, up 13.1% from the year before. That year, net income was $554.05M with a net margin of 17.4%, operating cash flow was $674.41M and free cash flow was $424.89M. The quarter ended Sep 30, 2026 had revenue of $1.31B and net income of $347.74M.
Revenue and Margins
The operating margin was 20.4% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $1.75B, a compound annual rate of 6.9%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $3.19B | +13.1% | 58.2% | 20.4% | 17.4% |
| Dec 2024 | $2.82B | +5.4% | 58.5% | 21.1% | 19.2% |
| Dec 2023 | $2.68B | -15.2% | 57.4% | 18.7% | 16.8% |
| Dec 2022 | $3.16B | -14.8% | 59.2% | 26.4% | 22.7% |
| Dec 2021 | $3.70B | +18.6% | 59.6% | 32.4% | 27.4% |
| Dec 2020 | $3.12B | +36.0% | 57.2% | 29.7% | 25.1% |
| Dec 2019 | $2.29B | +9.2% | 58.4% | 24.1% | 20.4% |
| Dec 2018 | $2.10B | -1.7% | 58.1% | 22.6% | 21.5% |
| Dec 2017 | $2.14B | +21.9% | 57.2% | 24.6% | 12.1% |
| Dec 2016 | $1.75B | N/A | 54.7% | -3.6% | -2.5% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 2.2% from the year before. In the quarter ended Sep 2026, net income rose 190.8% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.19B | $2.82B | $2.68B | $3.16B | $3.70B | $3.12B | $2.29B | $2.10B | $2.14B | $1.75B |
| Cost of revenue | $1.33B | $1.17B | $1.14B | $1.29B | $1.50B | $1.34B | $955.14M | $880.41M | $915.15M | $794.64M |
| Gross profit | $1.86B | $1.65B | $1.54B | $1.87B | $2.21B | $1.79B | $1.34B | $1.22B | $1.22B | $958.61M |
| Research and development | $504.60M | $460.88M | $418.09M | $440.59M | $427.61M | $374.96M | $322.82M | $301.50M | $307.31M | $292.16M |
| Operating income | $650.05M | $593.79M | $501.07M | $831.94M | $1.20B | $928.41M | $553.65M | $473.80M | $525.34M | -$62.97M |
| Net income | $554.05M | $542.37M | $448.75M | $715.50M | $1.01B | $784.15M | $467.47M | $451.78M | $257.69M | -$43.42M |
| EBITDA | $772.39M | $707.64M | $612.92M | $922.82M | $1.30B | $1.06B | $651.66M | $579.03M | $629.72M | $56.09M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.31B | $1.33B | $1.28B | $1.08B | $769.21M | $651.80M | $685.68M | $752.88M | $737.30M | $729.88M | $599.82M | $670.60M |
| Gross profit | $771.28M | $794.62M | $780.95M | $619.69M | $449.31M | $373.01M | $415.34M | $447.29M | $436.51M | $425.84M | $339.28M | $379.55M |
| Operating income | $401.97M | $437.81M | $473.00M | $293.20M | $145.30M | $90.74M | $120.80M | $153.58M | $152.06M | $210.37M | $77.77M | $124.32M |
| Net income | $347.74M | $374.88M | $398.91M | $257.22M | $119.56M | $78.37M | $98.90M | $146.25M | $145.65M | $186.27M | $64.20M | $117.06M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of $200.00M by $93.75M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $4.18B | $3.71B | $3.49B | $3.50B | $3.81B | $3.65B | $2.79B | $2.71B | $3.11B | $2.76B |
| Current assets | $1.95B | $1.82B | $2.16B | $2.26B | $2.58B | $2.42B | $1.66B | $1.73B | $2.27B | $1.62B |
| Cash and equivalents | $293.75M | $553.35M | $757.57M | $854.77M | $1.12B | $914.12M | $773.92M | $926.75M | $429.84M | $307.88M |
| Total liabilities | $1.39B | $889.42M | $960.93M | $1.05B | $1.25B | $1.44B | $1.31B | $1.18B | $1.16B | $933.83M |
| Short-term debt | $200.00M | $0 | $17.52M | $50.12M | $19.18M | $33.34M | $9.11M | $34.87M | $24.50M | $1.05M |
| Long-term debt | N/A | $0 | $0 | $0 | $89.24M | $376.77M | $394.69M | $379.98M | $365.99M | $352.67M |
| Shareholder equity | $2.80B | $2.82B | $2.53B | $2.45B | $2.56B | $2.21B | $1.48B | $1.52B | $1.95B | $1.83B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $5.45B | $4.93B | $4.43B | $4.17B | $3.96B | $3.76B | $3.71B | $3.71B | $3.77B | $3.63B | $3.41B | $3.49B |
| Total liabilities | $1.71B | $1.45B | $1.29B | $1.37B | $1.25B | $924.56M | $908.34M | $889.42M | $867.19M | $900.89M | $852.89M | $960.93M |
| Cash and equivalents | $460.74M | $349.54M | $241.94M | $293.75M | $272.70M | $339.25M | $475.63M | $553.35M | $510.04M | $421.90M | $707.40M | $757.57M |
| Shareholder equity | $3.69B | $3.44B | $3.14B | $2.80B | $2.72B | $2.84B | $2.80B | $2.82B | $2.90B | $2.73B | $2.56B | $2.53B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 63.0% of operating cash flow. Dividends and share repurchases together came to 183.2% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $674.41M | $672.18M | $585.23M | $577.92M | $1.10B | $868.93M | $578.75M | $476.88M | $626.50M | $455.20M |
| Capital expenditures | $249.53M | $730.15M | $159.64M | $163.25M | $132.47M | $184.98M | $134.64M | $114.38M | $105.38M | $85.27M |
| Free cash flow | $424.89M | -$57.98M | $425.59M | $414.67M | $965.89M | $683.96M | $444.11M | $362.50M | $521.12M | $369.93M |
| Dividends paid | $76.31M | $76.42M | $67.88M | $69.71M | $65.98M | $66.48M | $61.30M | $67.32M | $55.45M | $48.62M |
| Share repurchases | $702.10M | $198.57M | $397.24M | $752.08M | $600.00M | $88.47M | $500.00M | $823.48M | $200.30M | $146.33M |
| Investing cash flow | -$368.62M | -$622.34M | -$179.65M | $43.75M | $120.36M | -$569.79M | -$156.66M | $923.01M | -$262.80M | -$640.46M |
| Financing cash flow | -$562.25M | -$251.77M | -$501.91M | -$892.99M | -$1.01B | -$158.29M | -$574.35M | -$903.42M | -$245.19M | $228.44M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $313.61M | $469.14M | $265.12M | $281.64M | $49.05M | $182.09M | $161.64M | $282.56M | $166.27M | $216.07M | $7.28M | $248.78M |
| Capital expenditures | $97.19M | $100.74M | $64.73M | $62.89M | $66.84M | $52.77M | $67.03M | $62.38M | $54.25M | $569.50M | $44.02M | $44.34M |
| Free cash flow | $216.42M | $368.40M | $200.39M | $218.75M | -$17.79M | $129.32M | $94.61M | $220.17M | $112.02M | -$353.43M | -$36.74M | $204.44M |
Frequently Asked Questions About TER
What is Teradyne's annual revenue?
Teradyne reported revenue of $3.19B for the fiscal year ended Dec 31, 2025.
How fast is Teradyne's revenue growing?
Revenue was up 13.1% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 0.4%.
Is Teradyne profitable?
Yes. Teradyne reported net income of $554.05M for the fiscal year ended Dec 31, 2025, with a net margin of 17.4%.
How much free cash flow does TER generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $674.41M minus capital expenditures of $249.53M produced free cash flow of $424.89M.
How much debt does Teradyne have?
The balance sheet dated Dec 31, 2025 reported short-term debt of $200.00M and cash and equivalents of $293.75M.
TER pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts